Brief: Anatara Lifesciences Seeks Trading Halt
16/10/2023 01:51
Oct 16 (Reuters) - Anatara Lifesciences Ltd ANR.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON ANALYSIS OF
SECONDARY
ENDPOINTS FROM GARP IRRITABLE BOWEL SYNDROME TRIAL DATA
Source text for Eikon: ID:nASX2bqDj6
Further company coverage: ANR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anatara Lifesciences
See all newsAustralia's Anatara Lifesciences falls on discounted placement
Brief: Anatara Lifesciences Receives Firm Commitments For A$1.2M Placement
Brief: Anatara Lifesciences Seeks Trading Halt
Brief: Anatara Lifesciences Says Hong Kong Patent Granted For GARP Product
Brief: Anatara Lifesciences Seeks Trading Halt Pending Announcement Regarding Update On Phase II Garp-Ibs Trial